Characterization of antibodies
| Antigen . | CD . | Clone . | Conjugate . | Supplier . |
|---|---|---|---|---|
| HPCA1 | CD34 | 581 | Pacific Blue | BioLegend |
| PTPRC | CD45 | HI30 | APC/Cy7 | BioLegend |
| KIT | CD117 | 104D2 | PE/Cy | eBioscience |
| PD-L1 | CD274 | 29E.2A3 | PE | BioLegend |
| PD-1 | CD279 | EH12.2H7 | PE | BioLegend |
| IgG1 isotype control | n.c. | — | PE | BD Biosciences |
| Antigen . | CD . | Clone . | Conjugate . | Supplier . |
|---|---|---|---|---|
| HPCA1 | CD34 | 581 | Pacific Blue | BioLegend |
| PTPRC | CD45 | HI30 | APC/Cy7 | BioLegend |
| KIT | CD117 | 104D2 | PE/Cy | eBioscience |
| PD-L1 | CD274 | 29E.2A3 | PE | BioLegend |
| PD-1 | CD279 | EH12.2H7 | PE | BioLegend |
| IgG1 isotype control | n.c. | — | PE | BD Biosciences |
—, no clone available; APC, allophycocyanin; Cy7, cyanine 7; HPCA1, human precursor cell antigen 1; Ig, immunoglobulin; n.c., not yet clustered; PE, phycoerythrin; PTPRC, protein tyrosine phosphatase, receptor type C.